sertindole has been researched along with Metabolic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Hert, M; He, Y; Mittoux, A; Peuskens, J | 1 |
| Azorin, JM; Cochran, J; Moore, N; Peuskens, J; Toumi, M | 1 |
1 trial(s) available for sertindole and Metabolic Diseases
| Article | Year |
|---|---|
Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone.
Topics: Adult; Aged; Antipsychotic Agents; Blood Glucose; Blood Pressure; Body Mass Index; Chi-Square Distribution; Fasting; Female; Follow-Up Studies; Humans; Imidazoles; Indoles; Lipids; Male; Metabolic Diseases; Middle Aged; Risperidone; Schizophrenia; Sex Factors; Time Factors; Waist Circumference; Young Adult | 2011 |
1 other study(ies) available for sertindole and Metabolic Diseases
| Article | Year |
|---|---|
The European sertindole safety and exposure survey: a follow-up study of 8600 patients.
Topics: Adult; Age Factors; Antipsychotic Agents; Cardiovascular Diseases; Case-Control Studies; Death, Sudden, Cardiac; Europe; Female; Follow-Up Studies; Heart Diseases; Humans; Imidazoles; Indoles; Male; Metabolic Diseases; Middle Aged; Risk Factors; Sex Factors; Suicide | 2007 |